RecruitingPhase 1NCT03816345
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Sponsor: National Cancer Institute (NCI)
Baltimore, MD · Bethesda, MD · +48 more sites
4 recruiting ulcerative colitis studies with a site in Baltimore, MD.
Sponsor: National Cancer Institute (NCI)
Baltimore, MD · Bethesda, MD · +48 more sites
Sponsor: Sanofi
Baltimore, MD · Greenbelt, MD · +116 more sites
Sponsor: University of North Carolina, Chapel Hill
Baltimore, MD · +10 more sites
Sponsor: Takeda
Baltimore, MD · +21 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.